Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 859 | 1,590 | 1,073 | 3,427 | 0 |
| Gross Profit | 859 | 1,590 | 1,073 | 3,427 | N/A |
| Operating Expenses | 5,426 | 5,600 | 4,490 | 4,859 | 2,469 |
| Operating Income | -4,567 | -4,010 | -3,417 | -1,432 | -2,469 |
| Other Income | 20 | 10 | 4 | 5 | 1 |
| Pre-tax Income | -4,547 | -4,000 | -3,413 | -1,427 | -2,468 |
| Net Income Continuous | -4,547 | -4,000 | -3,413 | -1,427 | -2,468 |
| Net Income | $-4,547 | $-4,000 | $-3,413 | $-1,427 | $-2,468 |
| EPS Basic Total Ops | -177.50 | -162.25 | -139.25 | -61.00 | -117.75 |
| EPS Basic Continuous Ops | -177.42 | -163.03 | -139.21 | -60.90 | -107.65 |
| EPS Diluted Total Ops | -177.50 | -162.25 | -139.25 | -61.00 | -117.75 |
| EPS Diluted Continuous Ops | -177.42 | -163.03 | -139.21 | -60.90 | -107.65 |
| EBITDA(a) | $-4,536 | $-3,994 | $-3,396 | $-1,420 | $-2,458 |